First National Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.9M | Buy |
10,129
+158
| +2% | +$123K | 1.16% | 12 |
|
|
2025
Q1 | $8.23M | Sell |
9,971
-1,881
| -16% | -$1.55M | 1.32% | 12 |
|
|
2024
Q4 | $9.15M | Buy |
11,852
+334
| +3% | +$258K | 1.48% | 11 |
|
|
2024
Q3 | $10.2M | Buy |
11,518
+527
| +5% | +$467K | 1.63% | 11 |
|
|
2024
Q2 | $9.95M | Sell |
10,991
-1,008
| -8% | -$913K | 1.82% | 8 |
|
|
2024
Q1 | $7.13M | Buy |
11,999
+3,447
| +40% | +$2.05M | 1.59% | 9 |
|
|
2023
Q4 | $4.99M | Buy |
8,552
+2,695
| +46% | +$1.57M | 1.43% | 10 |
|
|
2023
Q3 | $3.15M | Buy |
5,857
+1,509
| +35% | +$811K | 1.4% | 11 |
|
|
2023
Q2 | $2.04M | Sell |
4,348
-734
| -14% | -$344K | 1.88% | 6 |
|
|
2023
Q1 | $1.75M | Buy |
5,082
+393
| +8% | +$135K | 1.98% | 7 |
|
|
2022
Q4 | $1.72M | Buy |
4,689
+507
| +12% | +$186K | 2.2% | 4 |
|
|
2022
Q3 | $1.35M | Buy |
4,182
+1,182
| +39% | +$382K | 2% | 5 |
|
|
2022
Q2 | $973K | Buy |
+3,000
| New | +$973K | 2.02% | 7 |
|